|
Published: 2024-03-04 17:06:20 CET
| |
Novozymes A/S
Decisions of general meeting
|
Resolutions from the Extraordinary Shareholders' Meeting 2024
Company Announcement no. 10 March 4, 2024
Today an extraordinary shareholders' meeting was conducted. The following resolutions were made:
-
Adoption of Novonesis A/S as secondary name and amendment of the Articles of Association in accordance herewith
-
Election of Jesper Brandgaard as Vice Chair of the Board of Directors
-
Election of Lise Kaae, Kevin Lane and Kim Stratton as members of the Board of Directors
Following the extraordinary shareholders' meeting, the Board of Directors consists of the following members:
-
Cornelis (Cees) de Jong, Chair
-
Jesper Brandgaard, Vice Chair
-
Heine Dalsgaard
-
Sharon James
-
Kasim Kutay
-
Lise Kaae
-
Kevin Lane
-
Morten Otto Alexander Sommer
-
Kim Stratton
Employee representatives:
-
Anne Breum
-
Anders Hentze Knudsen
-
Preben Nielsen
-
Jens Øbro
-
Karen Louise Lauesen, observer
-
Kim Ib Sørensen, observer
For further information on members of the Board of Directors, please go to www.novonesis.com
| | |
Attachment
|
Attachments:
2024_10_EGM_Resolutions.pdf
|
|
This news release was distributed by Company News System, www.nasdaqomxnordic.com/news/marketnotices
To subscribe on regulatory news from this company, go to the subscription page |
|
Disclaimer
Novozymes A/S published this content on
04 March 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
04 March 2024 16:09:05 UTC.